Tivic Health Systems Inc (NASDAQ:TIVC) — Market Cap & Net Worth
Market Cap & Net Worth: Tivic Health Systems Inc (TIVC)
Tivic Health Systems Inc (NASDAQ:TIVC) has a market capitalization of $2.65 Million ($2.65 Million) as of May 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29365 globally and #5740 in its home market, demonstrating a -17.86% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tivic Health Systems Inc's stock price $0.92 by its total outstanding shares 2877926 (2.88 Million). Analyse how efficiently does Tivic Health Systems Inc generate cash to see how efficiently the company converts income to cash.
Tivic Health Systems Inc Market Cap History: 2021 to 2026
Tivic Health Systems Inc's market capitalization history from 2021 to 2026. Data shows change from $1.12 Billion to $2.65 Million (-75.75% CAGR).
Index Memberships
Tivic Health Systems Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #875 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #2787 of 3165 |
Weight: Tivic Health Systems Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Tivic Health Systems Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tivic Health Systems Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
10.92x
Tivic Health Systems Inc's market cap is 10.92 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.12 Billion | $1.17 Million | -$8.49 Million | 957.66x | N/A |
| 2022 | $184.19 Million | $1.84 Million | -$10.10 Million | 100.10x | N/A |
| 2023 | $5.18 Million | $1.18 Million | -$8.24 Million | 4.40x | N/A |
| 2024 | $996.34K | $780.00K | -$5.66 Million | 1.28x | N/A |
| 2025 | $4.17 Million | $382.00K | -$8.88 Million | 10.92x | N/A |
Competitor Companies of TIVC by Market Capitalization
Companies near Tivic Health Systems Inc in the global market cap rankings as of May 2, 2026.
Key companies related to Tivic Health Systems Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Tivic Health Systems Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Tivic Health Systems Inc's market cap moved from $1.12 Billion to $ 2.65 Million, with a yearly change of -75.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.65 Million | -36.55% |
| 2025 | $4.17 Million | +318.83% |
| 2024 | $996.34K | -80.77% |
| 2023 | $5.18 Million | -97.19% |
| 2022 | $184.19 Million | -83.51% |
| 2021 | $1.12 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Tivic Health Systems Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.65 Million USD |
| MoneyControl | $2.65 Million USD |
| MarketWatch | $2.65 Million USD |
| marketcap.company | $2.65 Million USD |
| Reuters | $2.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tivic Health Systems Inc
Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In additio… Read more